Saltar al contenido
Merck

Potential role for ET-2 acting through ETA receptors in experimental colitis in mice.

Inflammation research : official journal of the European Histamine Research Society ... [et al.] (2016-10-26)
R F Claudino, D F Leite, A F Bento, J G Chichorro, J B Calixto, G A Rae
RESUMEN

This study attempted to clarify the roles of endothelins and mechanisms associated with ET Colitis was induced by intracolonic administration of 2,4,6-trinitrobenzene sulfonic acid (TNBS, 1.5 mg/animal) or dextran sulfate sodium (DSS, 3%). After colitis establishment, mice received Atrasentan (ET Atrasentan treatment ameliorates TNBS- and DSS-induced colitis. In the TNBS model was observed reduction in macroscopic and microscopic score, colon weight, neutrophil influx, IL-1β, MIP-2 and keratinocyte chemoattractant (KC) levels, inhibition of adhesion molecules expression and restoration of IL-10 levels. However, A192621 treatment did not modify any parameter. ET-1 and ET-2 mRNA was decreased 24 h, but ET-2 mRNA was markedly increased at 48 h after TNBS. ET-2 was able to potentiate LPS-induced KC production in vitro. ET Atrasentan treatment was effective in reducing the severity of colitis in DSS- and TNBS-treated mice, suggesting that ET

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Mechlorethamine hydrochloride, 98%
Sigma-Aldrich
BQ-123, ≥99%, sodium salt, lyophilized powder
Sigma-Aldrich
BQ-788, ≥95%, solid
Sigma-Aldrich
Endothelin 2 human, ≥97% (HPLC), powder